NL6907431A - - Google Patents

Info

Publication number
NL6907431A
NL6907431A NL6907431A NL6907431A NL6907431A NL 6907431 A NL6907431 A NL 6907431A NL 6907431 A NL6907431 A NL 6907431A NL 6907431 A NL6907431 A NL 6907431A NL 6907431 A NL6907431 A NL 6907431A
Authority
NL
Netherlands
Application number
NL6907431A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6907431A publication Critical patent/NL6907431A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL6907431A 1968-05-16 1969-05-14 NL6907431A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681767499 DE1767499A1 (de) 1968-05-16 1968-05-16 Verfahren zur Herstellung haltbarer Vitaminzubereitungen

Publications (1)

Publication Number Publication Date
NL6907431A true NL6907431A (xx) 1969-11-18

Family

ID=5699379

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6907431A NL6907431A (xx) 1968-05-16 1969-05-14

Country Status (12)

Country Link
AT (1) AT285811B (xx)
BE (1) BE733145A (xx)
BR (1) BR6908845D0 (xx)
CH (1) CH522405A (xx)
DE (1) DE1767499A1 (xx)
DK (1) DK122007B (xx)
ES (1) ES367284A1 (xx)
FR (1) FR2008690A1 (xx)
GB (1) GB1201014A (xx)
IL (1) IL32096A0 (xx)
NL (1) NL6907431A (xx)
SE (1) SE357304B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080673B1 (de) * 1981-11-28 1985-05-29 Roche Diagnostics GmbH Oral applizierte Zubereitungsformen von Guar-Mehl
US4721705A (en) * 1983-09-26 1988-01-26 Chemish Adviesbureau Drs. J.C.P. Schreuder B.V. Skin treatment compositions
DE4119306C2 (de) * 1991-06-12 1996-05-30 Wheli Inter Ag Organische Rohstoffe, Zwischen- und Endprodukte für die Ernährung und zur Verwendung für technische Zwecke, die Vitalstoffe enthalten
JPH06192104A (ja) 1992-09-14 1994-07-12 Vesta Medicines Pty Ltd 幼児における新陳代謝異常の治療および予防のための組成物
ZA936723B (en) * 1992-09-14 1995-08-14 Vesta Med Pty Ltd Pharmaceutical preparations for lowering homocysteine levels
DE19705555A1 (de) * 1997-02-13 1998-08-20 Ulrich Dr Posanski Pharmazeutische Präparate der Thioctsäure zur oralen Anwendung
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
PT1169322E (pt) 1999-03-08 2007-04-30 Medicure Inc Análogos de piridoxal para o tratamento de desordens causadas por uma deficiência em vitamina b-6.
AU5840200A (en) 1999-07-13 2001-01-30 Medicure Inc. Treatment of diabetes and related pathologies
WO2001013900A2 (en) 1999-08-24 2001-03-01 Medicure International Inc. Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
DK1268498T3 (da) 2000-02-29 2005-08-08 Medicure Int Inc Kardioprotektive phosphater
WO2001072309A2 (en) 2000-03-28 2001-10-04 Medicure International Inc. Treatment of cerebrovascular disease
CN1095472C (zh) * 2000-04-17 2002-12-04 上海复康医药科技发展有限公司 叶酸-多聚糖复合物,其制备方法和以该复合物为活性成分的药物组合物
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
EP1299358B1 (en) 2000-07-07 2007-06-13 Medicure International Inc. Pyridoxine and pyridoxal analogues as cardiovascular therapeutics
WO2006050598A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
WO2022005839A1 (en) 2020-06-30 2022-01-06 L'oreal Natural non-sulfate rinse-off cleansing compositions with high oil loading, and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2555463A (en) * 1949-03-28 1951-06-05 Parke Davis & Co Stabilized sodium pantothenate composition
FR1034595A (fr) * 1950-09-08 1953-07-27 Perfectionnements pour les traitements des hémicelluloses mannogalactanes, pour obtenir une imbibition retardée, propre aux fins thérapeutiques

Also Published As

Publication number Publication date
ES367284A1 (es) 1971-04-01
IL32096A0 (en) 1969-06-25
CH522405A (de) 1972-05-15
DK122007B (da) 1972-01-03
BE733145A (xx) 1969-11-17
DE1767499A1 (de) 1971-09-09
SE357304B (xx) 1973-06-25
GB1201014A (en) 1970-08-05
BR6908845D0 (pt) 1973-02-08
AT285811B (de) 1970-11-10
FR2008690A1 (xx) 1970-01-23

Similar Documents

Publication Publication Date Title
AU428130B2 (xx)
AU5184069A (xx)
AU6168869A (xx)
AU6171569A (xx)
AU429879B2 (xx)
AU4304568A (xx)
AU4811568A (xx)
AU4744468A (xx)
BE708888A (xx)
BE726953A (xx)
BE709415A (xx)
BE709320A (xx)
BE709319A (xx)
BE709301A (xx)
BE709274A (xx)
BE709138A (xx)
BE709119A (xx)
NL6907431A (xx)
BE709095A (xx)
BE726599A (xx)
BE708951A (xx)
BE708933A (xx)
BE709446A (xx)
BE642636A (xx)
BE630165A (xx)